USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Diagnostic Neuroimaging Markets and Emerging Applications, Forecast to 2022
Global Diagnostic Neuroimaging Markets and Emerging Applications, Forecast to 2022
Headways in Neuroimaging Continues to Play a Promising Care Pathway in Diagnosis and Treatment of Major Neurological Disorders
RELEASE DATE
13-Aug-2018
13-Aug-2018
REGION
North America
North America
Research Code: P9B6-01-00-00-00
SKU: HC03056-NA-MR_22180
$4,950.00
In stock
SKU
HC03056-NA-MR_22180
Description
The scope of this research study covers the diagnostic applications of advanced imaging in neurological and neurodegenerative disorders. The geographical market covered is North America (US), Europe, and Asia-Pacific (APAC).
Key Features
This research service provides the following metrics:
- A quantification of the size of procedure volumes for select neurology disorders (Alzheimer’s disease, Epilepsy, Parkinson’s disease, Multiple Sclerosis, Stroke and Brain Tumor) for the above-mentioned markets from 2017 to 2022
- Market forecasts presenting the incidence and prevalence population for neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
- Insight into brain imaging and neuroimaging technologies, insights into technology trends, future diagnostic and therapeutic perspectives, and competitive landscape
- Diagnostic imaging procedure volumes and service market revenue estimates for select neurology disorders (Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, Stroke and Brain Tumor) for the base year 2017
- Key insights on recent advancements in neuroinformatics initiatives and novel platforms shaping the future, including Artificial Intelligence (AI) applications in neuroimaging focusing on new advancements and future developments.
- Current key products and solutions offerings in neuroimaging software applications
- Growth opportunities and companies to action section that enlists the key roles that can be taken up by companies for growth along with an illustrative list of key company profiles including GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Ricoh, Hitachi, and Shimadzu
Key Issues Addressed
- What are some of the major neurological disorders burdening the society today and what potential treatments and breakthroughs can be expected in the near future?
- What major imaging modalities make up the neuroimaging market and what is the proportion of imaging techniques used for diagnosis and treatment of key neurological disorders?
- What is the estimated neuroimaging procedure volume and service market revenue of imaging technologies for different geographies like North America, Europe, and APAC?
- Are the vendors in the space ready to go it alone or do they need partnerships to take their businesses to the next level? Are there any novel start-ups and/or products?
- How is the role of neuroimaging technologies and solutions in the diagnosis and treatment pathways for neurological disorders changing? What are the current gold standards? How will future imaging technologies play a role to overcome the neurological disorders challenge, especially neurodegenrative disorders like Alzheimer's and Parkinson’s?
- Are the products and services offered today meeting customer needs or is additional development needed e.g., in neuroinformatics? Have Artificial Intelligence (AI) and machine learning started making an impact in neuroimaging? Are there any growth opportunities?
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Research Methodology
Study Scope
Key Findings—Executive Summary
Promising Care Delivery and Diagnosis in the Near Future for Neurodegenerative Disorders
Executive Summary—3 Big Predictions
Market Segmentation—Neurology Disorders
Market Segmentation—Medical Imaging Technologies
Neurological Disorders—Why They are a Burden to the Society?
Neurological Disorders—Global Burden in Terms of the Affected Population
Neurological Disorders Burden and Economic Impact
Introduction—Neuroimaging
Neuroimaging Categorization
Key Neurological and Neurodegenerative Disorders
Alzheimer’s Disease and Dementia
Parkinson’s Disease (PD)
Multiple Sclerosis
Epilepsy
Acute Stroke (Brain)
Brain Tumor/Cancer
Neuroimaging Technologies—MRI Imaging
Neuroimaging Technologies—CT Imaging
Neuroimaging Technologies—Positron Emission Tomography (PET)
Neuroimaging Technologies—PET-MR Hybrid Imaging
Neuroimaging Technologies—PET/CT and SPECT/CT Hybrid Imaging
Neuroimaging Technologies—Magnetoencephalography (MEG)
Neuroimaging Technologies—Near-infrared Spectroscopy (NIRS)
Treatment Lifecycle—Developing Role of Neuroimaging in Diagnostic and Treatment Pathways
Alzheimer’s Disease—Role of Brain Imaging in Diagnosis and Treatment
Alzheimer’s Disease—Future Treatment Perspectives
Parkinson’s Disease—Role of Brain Imaging in Diagnosis and Treatment
Parkinson’s Disease Modern Care Pathways—Advanced Role of Imaging in the Deep Brain Stimulation (DBS) Surgical Therapy and Monitoring
Parkinson’s Disease—Future Treatment Perspectives
Epilepsy—Role of Brain Imaging in Diagnosis and Treatment
Multiple Sclerosis—Role of Brain Imaging in Diagnosis and Treatment
Acute Stroke—Role of Brain Imaging in Diagnosis and Treatment
Brain Tumor/Cancer Lifecycle and Role of Imaging in the Clinical Care Pathway
Brain Tumor/Cancer—Role of Medical Imaging Technologies in Diagnosis and Treatment: Current Gold Standards
Neuroimaging Software Applications and Neuroinformatics
Neuroimaging Software Applications
AI Applications in Neuroimaging—New Advances and Future Developments
Quantitative Neuroimaging—A Promising Care Pathway
Recent Advancements in Neuroinformatics
Recent Advancements in Neuroinformatics—Initiatives and Novel Platforms Shaping the Future
Growth Opportunity—Image Quantification Applications
Companies to Action—Synthetic MR
Companies to Action—QMenta (A Disruptive Startup Company)
Companies to Action—Qubiotech (A Disruptive Start-up Company)
Vendor Profile—GE Healthcare
Vendor Profile—Siemens Healthineers
Vendor Profile—Philips Healthcare
Vendor Profile—Canon Medical Systems
Vendor Profile—Hitachi Medical Systems
Vendor Profile—Ricoh Company Ltd.
Vendor Profile—Near Infrared Spectroscopy
Vendor Profile—CorTechs Labs
Vendor Profile—Olea Medical
Vendor Profile—Combinostics
Vendor Profile—SyntheticMR
Alzheimer’s Disease—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Alzheimer’s Disease—Disease Prevalence and Incidence
Alzheimer’s Disease—Total Addressable Patient Population
Alzheimer’s Disease—Procedure Volume and Service Market Revenue Estimate
Alzheimer’s Disease—Disease Prevalence, Incidence, and Service Market Revenue Forecasts
Multiple Sclerosis—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Multiple Sclerosis—Disease Prevalence and Incidence
Multiple Sclerosis—Total Addressable Patient Population
Multiple Sclerosis—Procedure Volume and Service Market Revenue Estimate
Multiple Sclerosis—Disease Prevalence, Incidence, and Service
Market Revenue Forecasts
Parkinson’s Disease—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Parkinson’s Disease—Disease Prevalence and Incidence
Parkinson’s Disease—Total Addressable Patient Population
Parkinson’s Disease—Procedure Volume and Service Market Revenue Estimate
Parkinson’s Disease—Disease Prevalence, Incidence, and Service Market Revenue Forecasts
Epilepsy—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Epilepsy Disease—Disease Prevalence and Incidence
Epilepsy Disease—Total Addressable Patient Population
Epilepsy Disease—Procedure Volume and Service Market Revenue Estimate
Stroke—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Stroke—Disease Incidence (First Time Stroke) and Recurring Cases
Stroke—Total Addressable Patient Population
Stroke—Procedure Volume and Service Market Revenue Estimate
Brain Tumor—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies
Brain Tumor—Disease Prevalence and Incidence
Brain Tumor—Total Addressable Patient Population
Brain Tumor—Procedure Volume and Service Market Revenue Estimate
Overview of Neurodegenerative Diseases Reimbursement
The Last Word—3 Big Predictions
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
List of Exhibits
List of Figures- 1. Neurology Disorders Imaging Market: Proportion of Imaging Techniques and Percent of Incidence Population Examined by Diagnostic Imaging Technologies, Global, 2017
- 2. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population of Select Neurology Disorders, Global, 2017
- 3. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Alzheimer’s Disease by Imaging Technologies, Global, 2017
- 4. Neurology Disorders Imaging Market: Prevalence of Alzheimer’s Disease and Related Dementia, Global, 2017
- 5. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Alzheimer’s Disease, Global, 2017
- 6. Neurology Disorders Imaging Market: Procedure Volume Estimates by Imaging Technologies, Global, 2017
- 7. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 8. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Multiple Sclerosis by Imaging Technologies, Global, 2017
- 9. Neurology Disorders Imaging Market: Prevalence of Multiple Sclerosis Disease, Global, 2017
- 10. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Multiple Sclerosis, Global, 2017
- 11. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017
- 12. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 13. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Parkinson’s Disease by Imaging Technologies, Global, 2017
- 14. Neurology Disorders Imaging Market: Prevalence of Parkinson’s Disease, Global, 2017
- 15. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Parkinson’s Disease, Global, 2017
- 16. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017
- 17. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 18. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Epilepsy by Imaging Technologies, Global, 2017
- 19. Neurology Disorders Imaging Market: Prevalence of Epilepsy Disease, Global, 2017
- 20. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Epilepsy Disease, Global, 2017
- 21. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017
- 22. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 23. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Stroke by Imaging Technologies, Global, 2017
- 24. Neurology Disorders Imaging Market: Prevalence of Stroke Disease, Global, 2017
- 25. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Stroke, Global, 2017
- 26. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017
- 27. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 28. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Brain Tumor by Imaging Technologies, Global, 2017
- 29. Neurology Disorders Imaging Market: Prevalence of Brain Tumor Disease, Global, 2017
- 30. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Brain Tumor Disease, Global, 2017
- 31. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017
- 32. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017
- 33. Neurology Disorders Imaging Market: Reimbursement and Insurance Coverage for Select Neurological Disorders, Global, 2017
List of Charts- 1. Neurology Disorders Imaging Market: Service Revenue Market for Select Neurological Disorders, Global, 2017
- 2. Neurology Disorders Imaging Market: Schematic Structure of Major Neurological Disorders and Study Focus, Global, 2017
- 3. Neurology Disorders Imaging Market: Market Segmentation by Imaging Technologies, Global, 2017
- 4. Neurology Disorders Imaging Market: Number of DALYs Lost by Neurological Diseases, Global, 2015–2030
- 5. Neurology Disorders Imaging Market: Parkinson’s Disease Profile Snapshot, US, 2017
- 6. Neurology Disorders Imaging Market: Multiple Sclerosis Disease Profile Snapshot, US, 2017
- 7. Neurology Disorders Imaging Market: Epilepsy Disease Profile Snapshot, US, 2017
- 8. Neurology Disorders Imaging Market: Brain Stroke Disease Profile Snapshot, Global, 2017
- 9. Neurology Disorders Imaging Market: Brain Tumor/Cancer Disease Profile Snapshot, US, 2017
- 10. Neurology Disorders Imaging Market: Alzheimer’s Disease Future Treatment Perspectives Pathway, Global, 2017–2020
- 11. Neurology Disorders Imaging Market: Parkinson’s Disease Current Gold Standards in Diagnosis and Treatment Pathway, Global, 2017
- 12. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Alzheimer’s Disease, Global, 2017
- 13. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Alzheimer's by Regions, Global, 2017–2022
- 14. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Alzheimer's, Global, 2017–2022
- 15. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Multiple Sclerosis, Global, 2017
- 16. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Multiple Sclerosis, Global, 2017–2022
- 17. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Multiple Sclerosis by Imaging Technologies, Global, 2017–2022
- 18. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Parkinson’s Disease, Global, 2017
- 19. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Parkinson’s Disease, Global, 2017–2022
- 20. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Parkinson's Disease by Imaging Technologies, Global, 2017–2022
- 21. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Epilepsy Disease, Global, 2017
- 22. Neurology Disorders Imaging Market: Incidence and Recurring Population of Stroke, Global, 2017
- 23. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Brain Tumor Disease, Global, 2017
Popular Topics
The scope of this research study covers the diagnostic applications of advanced imaging in neurological and neurodegenerative disorders. The geographical market covered is North America (US), Europe, and Asia-Pacific (APAC).--BEGIN PROMO--
Key Features
This research service provides the following metrics:
- A quantification of the size of procedure volumes for select neurology disorders (Alzheimer’s disease, Epilepsy, Parkinson’s disease, Multiple Sclerosis, Stroke and Brain Tumor) for the above-mentioned markets from 2017 to 2022
- Market forecasts presenting the incidence and prevalence population for neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
- Insight into brain imaging and neuroimaging technologies, insights into technology trends, future diagnostic and therapeutic perspectives, and competitive landscape
- Diagnostic imaging procedure volumes and service market revenue estimates for select neurology disorders (Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, Stroke and Brain Tumor) for the base year 2017
- Key insights on recent advancements in neuroinformatics initiatives and novel platforms shaping the future, including Artificial Intelligence (AI) applications in neuroimaging focusing on new advancements and future developments.
- Current key products and solutions offerings in neuroimaging software applications
- Growth opportunities and companies to action section that enlists the key roles that can be taken up by companies for growth along with an illustrative list of key company profiles including GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Ricoh, Hitachi, and Shimadzu
Key Issues Addressed
- What are some of the major neurological disorders burdening the society today and w
| No Index | No |
|---|---|
| Podcast | No |
| Table of Contents | || Research Methodology~ | Executive Summary~ || Study Scope~ || Key Findings—Executive Summary~ || Promising Care Delivery and Diagnosis in the Near Future for Neurodegenerative Disorders~ || Executive Summary—3 Big Predictions~ | Market Segmentation~ || Market Segmentation—Neurology Disorders~ || Market Segmentation—Medical Imaging Technologies~ | Neurological Disorders—A Burden to the Society~ || Neurological Disorders—Why They are a Burden to the Society?~ || Neurological Disorders—Global Burden in Terms of the Affected Population~ || Neurological Disorders Burden and Economic Impact~ | Neuroimaging, Neurology Disorders, and Neurodegenerative Diseases—Introduction~ || Introduction—Neuroimaging~ || Neuroimaging Categorization~ || Key Neurological and Neurodegenerative Disorders~ || Alzheimer’s Disease and Dementia~ || Parkinson’s Disease (PD)~ || Multiple Sclerosis~ || Epilepsy~ || Acute Stroke (Brain)~ || Brain Tumor/Cancer~ | Key Neuroimaging Technologies~ || Neuroimaging Technologies—MRI Imaging~ || Neuroimaging Technologies—CT Imaging~ || Neuroimaging Technologies—Positron Emission Tomography (PET)~ || Neuroimaging Technologies—PET-MR Hybrid Imaging~ || Neuroimaging Technologies—PET/CT and SPECT/CT Hybrid Imaging~ || Neuroimaging Technologies—Magnetoencephalography (MEG)~ || Neuroimaging Technologies—Near-infrared Spectroscopy (NIRS)~ | Role of Advanced Neuroimaging in Diagnosis and Treatment of Neurological Disorders and Neurodegenerative Diseases—Emerging Care Pathways~ || Treatment Lifecycle—Developing Role of Neuroimaging in Diagnostic and Treatment Pathways~ || Alzheimer’s Disease—Role of Brain Imaging in Diagnosis and Treatment~ || Alzheimer’s Disease—Future Treatment Perspectives~ || Parkinson’s Disease—Role of Brain Imaging in Diagnosis and Treatment~ || Parkinson’s Disease Modern Care Pathways—Advanced Role of Imaging in the Deep Brain Stimulation (DBS) Surgical Therapy and Monitoring~ || Parkinson’s Disease—Future Treatment Perspectives~ || Epilepsy—Role of Brain Imaging in Diagnosis and Treatment~ || Multiple Sclerosis—Role of Brain Imaging in Diagnosis and Treatment~ || Acute Stroke—Role of Brain Imaging in Diagnosis and Treatment~ || Brain Tumor/Cancer Lifecycle and Role of Imaging in the Clinical Care Pathway~ || Brain Tumor/Cancer—Role of Medical Imaging Technologies in Diagnosis and Treatment: Current Gold Standards~ | Software Applications in Neuroimaging and Role of Neuroinformatics~ || Neuroimaging Software Applications and Neuroinformatics~ || Neuroimaging Software Applications~ || AI Applications in Neuroimaging—New Advances and Future Developments~ || Quantitative Neuroimaging—A Promising Care Pathway~ || Recent Advancements in Neuroinformatics~ || Recent Advancements in Neuroinformatics—Initiatives and Novel Platforms Shaping the Future~ | Growth Opportunities and Companies to Action~ || Growth Opportunity—Image Quantification Applications~ || Companies to Action—Synthetic MR~ || Companies to Action—QMenta (A Disruptive Startup Company)~ || Companies to Action—Qubiotech (A Disruptive Start-up Company)~ | Competitive Landscape—Key Vendor Profiles~ || Vendor Profile—GE Healthcare~ || Vendor Profile—Siemens Healthineers~ || Vendor Profile—Philips Healthcare~ || Vendor Profile—Canon Medical Systems~ || Vendor Profile—Hitachi Medical Systems~ || Vendor Profile—Ricoh Company Ltd.~ || Vendor Profile—Near Infrared Spectroscopy~ || Vendor Profile—CorTechs Labs~ || Vendor Profile—Olea Medical~ || Vendor Profile—Combinostics~ || Vendor Profile—SyntheticMR~ | Neurology Disorders Imaging Market—Procedure Volumes and Service Market Revenue Estimates~ || Alzheimer’s Disease—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Alzheimer’s Disease—Disease Prevalence and Incidence~ || Alzheimer’s Disease—Total Addressable Patient Population~ || Alzheimer’s Disease—Procedure Volume and Service Market Revenue Estimate~ || Alzheimer’s Disease—Disease Prevalence, Incidence, and Service Market Revenue Forecasts~ || Multiple Sclerosis—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Multiple Sclerosis—Disease Prevalence and Incidence~ || Multiple Sclerosis—Total Addressable Patient Population~ || Multiple Sclerosis—Procedure Volume and Service Market Revenue Estimate~ || Multiple Sclerosis—Disease Prevalence, Incidence, and Service ~ || Market Revenue Forecasts~ || Parkinson’s Disease—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Parkinson’s Disease—Disease Prevalence and Incidence~ || Parkinson’s Disease—Total Addressable Patient Population~ || Parkinson’s Disease—Procedure Volume and Service Market Revenue Estimate~ || Parkinson’s Disease—Disease Prevalence, Incidence, and Service Market Revenue Forecasts~ || Epilepsy—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Epilepsy Disease—Disease Prevalence and Incidence~ || Epilepsy Disease—Total Addressable Patient Population~ || Epilepsy Disease—Procedure Volume and Service Market Revenue Estimate~ || Stroke—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Stroke—Disease Incidence (First Time Stroke) and Recurring Cases~ || Stroke—Total Addressable Patient Population~ || Stroke—Procedure Volume and Service Market Revenue Estimate~ || Brain Tumor—Disease Overview and Proportion of Imaging Studies Examined by Imaging Technologies~ || Brain Tumor—Disease Prevalence and Incidence~ || Brain Tumor—Total Addressable Patient Population~ || Brain Tumor—Procedure Volume and Service Market Revenue Estimate~ || Overview of Neurodegenerative Diseases Reimbursement~ | The Last Word~ || The Last Word—3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || Learn More—Next Steps~ || List of Exhibits~ | The Frost & Sullivan Story~ |
| List of Charts and Figures | 1. Neurology Disorders Imaging Market: Proportion of Imaging Techniques and Percent of Incidence Population Examined by Diagnostic Imaging Technologies, Global, 2017~ 2. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population of Select Neurology Disorders, Global, 2017~ 3. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Alzheimer’s Disease by Imaging Technologies, Global, 2017~ 4. Neurology Disorders Imaging Market: Prevalence of Alzheimer’s Disease and Related Dementia, Global, 2017~ 5. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Alzheimer’s Disease, Global, 2017~ 6. Neurology Disorders Imaging Market: Procedure Volume Estimates by Imaging Technologies, Global, 2017~ 7. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 8. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Multiple Sclerosis by Imaging Technologies, Global, 2017~ 9. Neurology Disorders Imaging Market: Prevalence of Multiple Sclerosis Disease, Global, 2017~ 10. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Multiple Sclerosis, Global, 2017~ 11. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017~ 12. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 13. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Parkinson’s Disease by Imaging Technologies, Global, 2017~ 14. Neurology Disorders Imaging Market: Prevalence of Parkinson’s Disease, Global, 2017~ 15. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Parkinson’s Disease, Global, 2017~ 16. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017~ 17. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 18. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Epilepsy by Imaging Technologies, Global, 2017~ 19. Neurology Disorders Imaging Market: Prevalence of Epilepsy Disease, Global, 2017~ 20. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Epilepsy Disease, Global, 2017~ 21. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017~ 22. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 23. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Stroke by Imaging Technologies, Global, 2017~ 24. Neurology Disorders Imaging Market: Prevalence of Stroke Disease, Global, 2017~ 25. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Stroke, Global, 2017~ 26. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017~ 27. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 28. Neurology Disorders Imaging Market: Proportion of Imaging Studies Examined for Brain Tumor by Imaging Technologies, Global, 2017~ 29. Neurology Disorders Imaging Market: Prevalence of Brain Tumor Disease, Global, 2017~ 30. Neurology Disorders Imaging Market: Addressable Patient Population for Diagnostic Imaging Procedure Volumes in Brain Tumor Disease, Global, 2017~ 31. Neurology Disorders Imaging Market: Procedure Volume Estimate by Imaging Technologies, Global, 2017~ 32. Neurology Disorders Imaging Market: Service Revenues Estimate by Imaging Technologies, Global, 2017~ 33. Neurology Disorders Imaging Market: Reimbursement and Insurance Coverage for Select Neurological Disorders, Global, 2017~| 1. Neurology Disorders Imaging Market: Service Revenue Market for Select Neurological Disorders, Global, 2017~ 2. Neurology Disorders Imaging Market: Schematic Structure of Major Neurological Disorders and Study Focus, Global, 2017~ 3. Neurology Disorders Imaging Market: Market Segmentation by Imaging Technologies, Global, 2017~ 4. Neurology Disorders Imaging Market: Number of DALYs Lost by Neurological Diseases, Global, 2015–2030~ 5. Neurology Disorders Imaging Market: Parkinson’s Disease Profile Snapshot, US, 2017~ 6. Neurology Disorders Imaging Market: Multiple Sclerosis Disease Profile Snapshot, US, 2017~ 7. Neurology Disorders Imaging Market: Epilepsy Disease Profile Snapshot, US, 2017~ 8. Neurology Disorders Imaging Market: Brain Stroke Disease Profile Snapshot, Global, 2017~ 9. Neurology Disorders Imaging Market: Brain Tumor/Cancer Disease Profile Snapshot, US, 2017~ 10. Neurology Disorders Imaging Market: Alzheimer’s Disease Future Treatment Perspectives Pathway, Global, 2017–2020~ 11. Neurology Disorders Imaging Market: Parkinson’s Disease Current Gold Standards in Diagnosis and Treatment Pathway, Global, 2017~ 12. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Alzheimer’s Disease, Global, 2017~ 13. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Alzheimer's by Regions, Global, 2017–2022~ 14. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Alzheimer's, Global, 2017–2022~ 15. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Multiple Sclerosis, Global, 2017~ 16. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Multiple Sclerosis, Global, 2017–2022~ 17. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Multiple Sclerosis by Imaging Technologies, Global, 2017–2022~ 18. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Parkinson’s Disease, Global, 2017~ 19. Neurology Disorders Imaging Market: Disease Prevalence and Incidence Population Forecast for Parkinson’s Disease, Global, 2017–2022~ 20. Neurology Disorders Imaging Market: Service Revenue Market Forecast for Parkinson's Disease by Imaging Technologies, Global, 2017–2022~ 21. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Epilepsy Disease, Global, 2017~ 22. Neurology Disorders Imaging Market: Incidence and Recurring Population of Stroke, Global, 2017~ 23. Neurology Disorders Imaging Market: Prevalence and Incidence Population of Brain Tumor Disease, Global, 2017~ |
| Author | Ranjeet Marawar |
| Industries | Healthcare |
| WIP Number | P9B6-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9566-B1,9570-B1,9600-B1,9614-B1 |
Similar Research
Check items to add to the cart or
